ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

Emerging Growth Research Releases Q3 2025 Update Report on 22nd Century Group

By: Newsfile

New York, New York--(Newsfile Corp. - November 26, 2025) - Emerging Growth Research today released its latest quarterly update report on 22nd Century Group, Inc. (NASDAQ: XXII), highlighting the Company's now cash-rich balance sheet, full debt repayment, settlement of a $9.5 million insurance case, and stabilization of its Contract Manufacturing Operations (CMO). The updated report also reflects management's revised outlook for EBITDA breakeven, now expected in Q3 2026.

Key Highlights from the Update Report:

  • 22nd Century Group has fully repaid all remaining debt and settled its long-running $9.5 million insurance-related legal case, giving the Company a materially strengthened net-cash position.
  • Q3 2025 revenue of $4.0 million represents stabilization following restructuring and the 2024 CMO price-hike attrition.
  • Gross profit declined to $(1.1) million due to higher excise taxes, despite underlying per-unit margin improvement.
  • Operating loss improved year-over-year to $(3.2) million as SG&A expenses continued to tighten.
  • Adjusted EBITDA was $(2.6) million, remaining stable compared to prior quarters.
  • Net cash increased to $14.0 million in Q3 2025, compared to $(0.8) million in Q2 2025.
  • Management maintains confidence in reaching EBITDA breakeven by Q3 2026 on higher-margin CMO mix and VLN® expansion.
  • VLN® rollout continues, with state registrations now covering nearly all U.S. states and initial shipments underway.

For a copy of the full quarterly report, please visit:

https://emerginggrowth.com/wp-content/uploads/2025/11/XXII_Update_11.26.25.pdf

or

http://www.EmergingGrowth.com/profile/xxii/ (on the right side of the page as you scroll down)

About the Company

22nd Century Group, Inc. (NASDAQ: XXII) is a U.S.-based contract manufacturer for combustible tobacco products and the sole provider of VLN® reduced-nicotine cigarettes. With a focus on nicotine harm reduction and a stabilized CMO business, the Company is positioned to drive growth through its proprietary VLN® products while leveraging its operational capacity to scale higher-margin offerings. Founded in 1998, it is headquartered in Mocksville, NC.

Contact

Emerging Growth Research

Research@EmergingGrowth.com 

www.EmergingGrowth.com

Forward-Looking Statements

This press release contains forward-looking statements, including expectations regarding EBITDA breakeven timing, anticipated CMO and VLN® revenue growth, long-term financial performance, cash utilization, and potential dilution related to warrants or preferred share conversions. Actual results may differ materially due to risks and uncertainties. Readers are encouraged to review the full disclosure and risk factors included in the complete Emerging Growth Research update report.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/276032

Recent Quotes

View More
Symbol Price Change (%)
AMZN  233.22
+4.06 (1.77%)
AAPL  278.85
+1.30 (0.47%)
AMD  217.53
+3.29 (1.54%)
BAC  53.65
+0.66 (1.25%)
GOOG  320.12
-0.16 (-0.05%)
META  647.95
+14.34 (2.26%)
MSFT  492.01
+6.51 (1.34%)
NVDA  177.00
-3.26 (-1.81%)
ORCL  201.95
-3.01 (-1.47%)
TSLA  430.17
+3.59 (0.84%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.